Exercise-Induced Molecular Adaptations in Chronic Non-Communicable Diseases-Narrative Review.
Confidence:
0.12
Neuroplastic Effects Induced by Hypercapnic Hypoxia in Rat Focal Ischemic Stroke Are Driven via BDNF and VEGF Signaling.
Confidence:
0.06
Mollugin: A Comprehensive Review of Its Multifaceted Pharmacological Properties and Therapeutic Potential.
Confidence:
0.02
Transcranial Stimulation Methods in the Treatment of MDD Patients-The Role of the Neurotrophin System.
Confidence:
0.08
Role of Genetic and Epigenetic Biomarkers in Treatment-Resistant Depression: A Literature Review.
Confidence:
0.02
Comparison of Acute Irisin and Cognitive Responses to Different Exercise Modalities Among Late Adolescents.
Confidence:
0.08
Effect of Proximity to Failure in Resistance Training on Circulating Levels of Neuroprotective Biomarkers.
Confidence:
0.13
Modulation of BDNF/TrkB Signalling Pathway in Alzheimer's Disease: Mechanistic Insights and the Role of Stem Cell Therapy.
Confidence:
0.13
Protective Functions of ฮฒ-Alanyl-L-Histidine and Glycyl-L-Histidyl-L-Lysine Glycoconjugates and Copper in Concert.
Confidence:
0
Chronic Stress and Astrocyte Dysfunction in Depression: Molecular Mechanisms and Gene Expression Changes.
Confidence:
0.08
In vivo, in silico effects of sakuranetin as a multi-target nutraceutical against PTZ-induced seizures via GABA restoration and BDNF/TrkB activation.
Confidence:
0.16
Accelerated biological aging underlies the link between heavy metal mixture exposure and depression: A multi-omics study.
Confidence:
0.03
Associations Between Genetic Polymorphisms and Psychological Variables in Women With Fibromyalgia: A Cross-Sectional Study.
Confidence:
0.02
Prognostic impact of endocrine therapy and BDNF-TrkB axis in breast cancer brain metastases.
Confidence:
0.12
Bone hypertrophy and reduced quality after nucleus pulposus aspiration induces low back pain-like behavior and neuronal hyperexcitability.
Confidence:
0.13
Connections Between Prefrontal Cortex Anatomy and Autism Spectrum Disorder: A Literature Review.
Confidence:
0.06
Optogenetic stimulation attenuates central post-stroke pain via BDNF/TrkB signaling pathway modulation in the ascending pain modulation system.
Confidence:
0.08